Abstract
Viral particles and virus-like particles (VLPs) or capsids are becoming important vehicles and templates in bio-imaging, drug delivery and materials sciences. Viral particles are prepared by infecting the host organism but VLPs are obtained from cells that express a capsid protein. Some VLPs are disassembled and then re-assembled to incorporate a material of interest. Cell-free systems, which are amenable to manipulating the viral assembly process, are also available for producing viral particles. Regardless of the production system employed, the particles are functionalized by genetic and/or chemical engineering. Here, we review various methods for producing and functionalizing viral particles and VLPs, and we discuss the merits of each system.
Similar content being viewed by others
References
Cadena-Nava RD, Hu Y, Garmann RF, Ng B, Zelikin AN, Knobler CM, Gelbart WM (2011) Exploiting fluorescent polymers to probe the self-assembly of virus-like particles. J Phys Chem B 115:2386–2391
Chen PY, Dang X, Klug MT, Qi J, Dorval Courchesne NM, Burpo FJ, Fang N, Hammond PT, Belcher AM (2013) Versatile three-dimensional virus-based template for dye-sensitized solar cells with improved electron transport and light harvesting. ACS Nano 7:6563–6574
Chuan YP, Fan YY, Lua LH, Middelberg AP (2010) Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres. J R Soc Interface 7:409–421
Chuan YP, Rivera-Hernandez T, Wibowo N, Connors NK, Wu Y, Hughes FK, Lua LH, Middelberg AP (2013) Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine. Biotechnol Bioeng 110:2343–2351
Enomoto T, Kukimoto I, Kawano MA, Yamaguchi Y, Berk AJ, Handa H (2011) In vitro reconstitution of SV40 particles that are composed of VP1/2/3 capsid proteins and nucleosomal DNA and direct efficient gene transfer. Virology 420:1–9
Fiedler JD, Brown SD, Lau JL, Finn MG (2010) RNA-directed packaging of enzymes within virus-like particles. Angew Chem 49:9648–9651
Hovlid ML, Steinmetz NF, Laufer B, Lau JL, Kuzelka J, Wang Q, Hyypia T, Nemerow GR, Kessler H, Manchester M, Finn MG (2012) Guiding plant virus particles to integrin-displaying cells. Nanoscale 4:3698–3705
Kitai Y, Fukuda H, Enomoto T, Asakawa Y, Suzuki T, Inouye S, Handa H (2011) Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor. J Biotechnol 155:251–256
Kobayashi T, Nakamura Y, Mikami S, Masutani M, Machida K, Imataka H (2012) Synthesis of encephalomyocarditis virus in a cell-free system: from DNA to RNA virus in one tube. Biotechnol Lett 34:67–73
Kobayashi T, Yukigai J, Ueda K, Machida K, Masutani M, Nishino Y, Miyazawa A, Imataka H (2013) Purification and visualization of encephalomyocarditis virus synthesized by an in vitro protein expression system derived from mammalian cell extract. Biotechnol Lett 35:309–314
Kobayashi T, Machida K, Imataka H (2014) Human cell extract-derived cell-free systems for virus synthesis. Methods Mol Biol 1118:149–156
Lee YJ, Yi H, Kim WJ, Kang K, Yun DS, Strano MS, Ceder G, Belcher AM (2009) Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 324:1051–1055
Lee YJ, Lee Y, Oh D, Chen T, Ceder G, Belcher AM (2010) Biologically activated noble metal alloys at the nanoscale: for lithium ion battery anodes. Nano Lett 10:2433–2440
Liew MW, Rajendran A, Middelberg AP (2010) Microbial production of virus-like particle vaccine protein at gram-per-litre levels. J Biotechnol 150:224–231
Nuraje N, Dang X, Qi J, Allen MA, Lei Y, Belcher AM (2012) Biotemplated synthesis of perovskite nanomaterials for solar energy conversion. Adv Mater 24:2885–2889
Oh D, Qi J, Lu YC, Zhang Y, Shao-Horn Y, Belcher AM (2013) Biologically enhanced cathode design for improved capacity and cycle life for lithium-oxygen batteries. Nat Commun 4:2756
Patel KG, Swartz JR (2011) Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry. Bioconjugate Chem 22:376–387
Patterson DP, Prevelige PE, Douglas T (2012) Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. ACS Nano 6:5000–5009
Patterson DP, Schwarz B, Waters RS, Gedeon T, Douglas T (2014) Encapsulation of an enzyme cascade within the bacteriophage P22 virus-like particle. ACS Chem Biol 9:359–365
Pokorski JK, Hovlid ML, Finn MG (2011) Cell targeting with hybrid Qbeta virus-like particles displaying epidermal growth factor. Chembiochem 12:2441–2447
Pushko P, Pumpens P, Grens E (2013) Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures. Intervirology 56:141–165
Rhee JK, Hovlid M, Fiedler JD, Brown SD, Manzenrieder F, Kitagishi H, Nycholat C, Paulson JC, Finn MG (2011) Colorful virus-like particles: fluorescent protein packaging by the Qbeta capsid. Biomacromolecules 12:3977–3981
Rurup WF, Verbij F, Koay MS, Blum C, Subramaniam V, Cornelissen JJ (2014) Predicting the loading of virus-like particles with fluorescent proteins. Biomacromolecules 15:558–563
Soto CM, Ratna BR (2010) Virus hybrids as nanomaterials for biotechnology. Curr Opin Biotechnol 21:426–438
Strable E, Finn MG (2009) Chemical modification of viruses and virus-like particles. Curr Top Microbiol Immunol 327:1–21
Wen AM, Shukla S, Saxena P, Aljabali AA, Yildiz I, Dey S, Mealy JE, Yang AC, Evans DJ, Lomonossoff GP, Steinmetz NF (2012) Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules 13:3990–4001
Wu Y, Yang H, Shin HJ (2014) Encapsulation and crystallization of Prussian blue nanoparticles by cowpea chlorotic mottle virus capsids. Biotechnol Lett 36:515–521
Xing L, Li TC, Mayazaki N, Simon MN, Wall JS, Moore M, Wang CY, Takeda N, Wakita T, Miyamura T, Cheng RH (2010) Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 285:33175–33183
Yi H, Ghosh D, Ham MH, Qi J, Barone PW, Strano MS, Belcher AM (2012) M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors. Nano Lett 12:1176–1183
Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z (2011) Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjugate Chem 22:346–352
Acknowledgments
We would like to acknowledge the fact that viral particles and VLPs have been produced by many authors in addition to those cited here. We apologize to authors whose papers were not mentioned, due to the limited space in this review article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Machida, K., Imataka, H. Production methods for viral particles. Biotechnol Lett 37, 753–760 (2015). https://doi.org/10.1007/s10529-014-1741-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-014-1741-9